Bingol N - Search Results

1

The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia.

Sonmez A, Dogru T, Tasci I, Yilmaz MI, Pinar M, Naharci I, Bingol N, Kilic S, Demirtas A, Bingol S, Ozgurtas T, Erikci S. Sonmez A, et al. Among authors: bingol s, bingol n. Clin Endocrinol (Oxf). 2006 May;64(5):567-72. doi: 10.1111/j.1365-2265.2006.02510.x. Clin Endocrinol (Oxf). 2006. PMID: 16649978

2

Adiponectin may play a part in the pathogenesis of diabetic retinopathy.

Yilmaz MI, Sonmez A, Acikel C, Celik T, Bingol N, Pinar M, Bayraktar Z, Ozata M. Yilmaz MI, et al. Among authors: bingol n. Eur J Endocrinol. 2004 Jul;151(1):135-40. doi: 10.1530/eje.0.1510135. Eur J Endocrinol. 2004. PMID: 15248834

3

Blockade of the renin-angiotensin system increases plasma adiponectin levels in type-2 diabetic patients with proteinuria.

Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Acikel C, Kilic S, Bingol N, Bingol S, Vural A. Yenicesu M, et al. Among authors: bingol s, bingol n. Nephron Clin Pract. 2005;99(4):c115-21. doi: 10.1159/000083929. Epub 2005 Feb 10. Nephron Clin Pract. 2005. PMID: 15711099

4

The association of plasma adiponectin levels with hypertensive retinopathy.

Yilmaz MI, Sonmez A, Kilic S, Celik T, Bingol N, Pinar M, Mumcuoglu T, Ozata M. Yilmaz MI, et al. Among authors: bingol n. Eur J Endocrinol. 2005 Feb;152(2):233-40. doi: 10.1530/eje.1.01851. Eur J Endocrinol. 2005. PMID: 15745931

5

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S, Ozgurtas T, Bingol S. Dogru T, et al. Among authors: bingol n. Diabetes Res Clin Pract. 2007 Apr;76(1):24-9. doi: 10.1016/j.diabres.2006.07.031. Epub 2006 Sep 7. Diabetes Res Clin Pract. 2007. PMID: 16956691

6

Plasma apelin is lower in patients with elevated LDL-cholesterol.

Tasci I, Dogru T, Naharci I, Erdem G, Yilmaz MI, Sonmez A, Bingol N, Kilic S, Bingol S, Erikci S. Tasci I, et al. Among authors: bingol n. Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):428-32. doi: 10.1055/s-2007-971067. Exp Clin Endocrinol Diabetes. 2007. PMID: 17647139

7

Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.

Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural A, Ozdemir IC. Ozata M, et al. Among authors: bingol n. J Clin Endocrinol Metab. 2002 Feb;87(2):853-8. doi: 10.1210/jcem.87.2.8243. J Clin Endocrinol Metab. 2002. PMID: 11836332

8

Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.

Yilmaz MI, Sonmez A, Caglar K, Gok DE, Eyileten T, Yenicesu M, Acikel C, Bingol N, Kilic S, Oguz Y, Vural A. Yilmaz MI, et al. Among authors: bingol n. Endocrine. 2004 Dec;25(3):207-14. doi: 10.1385/ENDO:25:3:207. Endocrine. 2004. PMID: 15758247 Clinical Trial.

9

Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases.

Avcu F, Ural AU, Yilmaz MI, Bingol N, Nevruz O, Caglar K. Avcu F, et al. Among authors: bingol n. Int J Hematol. 2006 Apr;83(3):254-8. doi: 10.1532/IJH97.NA0411. Int J Hematol. 2006. PMID: 16720558

10

Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.

Ozata M, Gungor D, Turan M, Ozisik G, Bingol N, Ozgurtas T, Ozdemir IC. Ozata M, et al. Among authors: bingol n. J Clin Endocrinol Metab. 2001 Aug;86(8):3659-64. doi: 10.1210/jcem.86.8.7708. J Clin Endocrinol Metab. 2001. PMID: 11502793 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters